How to Read: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [Reading Guide]

This guide will help you navigate "Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012" efficiently, using a three-pass approach to extract key information, understand its methodology, and critically evaluate its findings.

First pass (5–10 min)

The goal of the first pass is to get a high-level overview and decide if the paper is relevant to your interests.

• What to skim:

  • Title: "Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012." This immediately tells you the paper's scope (global cancer statistics), the dataset (GLOBOCAN 2012), and its focus (data sources, methods, and key patterns).
  • Introduction (Section 1): Read the first and last paragraphs. The first paragraph will introduce GLOBOCAN and the problem it addresses (lack of comprehensive global cancer statistics). The last paragraph will outline the paper's objectives: to describe the data sources, methods, and major patterns of cancer incidence and mortality in GLOBOCAN 2012.
  • Conclusion (Section 5): Read this section to grasp the main findings, the overall significance of GLOBOCAN, and the acknowledged limitations.
  • Figures and Tables: Quickly glance at a few prominent figures like Figure 1 (Estimated age-standardized incidence rates) or Figure 2 (Estimated age-standardized mortality rates) to visualize the global scope, and Table 2 (Leading cancer types) to see the major cancers discussed.

• What to notice:

  • Contributions: This paper is a foundational description of the GLOBOCAN 2012 database, providing the methodology and key findings. Its main contribution is making global cancer burden data accessible and understandable, along with the methods used to derive it.
  • Problem: The core problem addressed is the scarcity and variability of reliable cancer incidence and mortality data worldwide, especially in low-resource settings, and how GLOBOCAN attempts to bridge these gaps through standardized estimation.
  • Setting: The paper focuses on a global scale, presenting data aggregated by country, region, and income level, providing a worldwide snapshot of cancer epidemiology.

Second pass (up to 1 hour)

Using SpatialRead in the Second Pass

• Use the Screenshot tool to capture figures, tables, diagrams, and formulae from the PDF and use AI for simple explanations.
• Ask: "Explain Figure X at a high level", "Compare Table 2 vs 3", or "What does the y-axis represent here?"
• Download SpatialRead →

In the second pass, you'll delve deeper into the paper to understand its core arguments, methods, and main results.

• What sections/figures to focus on:

  • Section 2: Sources of cancer incidence and mortality data: Read this section to understand the foundation of GLOBOCAN. Pay close attention to Table 1 (Data sources for GLOBOCAN 2012), which categorizes countries by the quality and type of data available (e.g., high-quality registry data, national mortality statistics, or no data). This table is crucial for understanding the reliability of estimates for different regions.
  • Section 3: Methods for estimating cancer incidence and mortality: This is the methodological heart of the paper. Skim subsections 3.1 (Data quality assessment), 3.2 (Estimation methods for incidence), and 3.3 (Estimation methods for mortality). Focus on understanding the different approaches used based on data availability, such as direct use of observed rates, estimation from mortality data, or modeling based on neighboring populations. Don't get bogged down in every detail, but grasp the general strategy.
  • Section 4: Major patterns of cancer incidence and mortality: This section presents the key findings.
    • Section 4.1 (Global burden): Focus on the overall numbers and the visual representation in Figure 1 (Estimated age-standardized incidence rates) and Figure 2 (Estimated age-standardized mortality rates). These maps show the geographical distribution of the cancer burden.
    • Section 4.2 (Leading cancer types): Examine Table 2 (Leading cancer types by sex and region) and Figure 3 (Leading cancer types worldwide by sex). These clearly illustrate which cancers are most prevalent and deadly globally and by sex.
    • Section 4.3 (Trends): Read this subsection to understand how cancer patterns are changing over time, though the paper primarily focuses on the 2012 snapshot.
  • Conclusion (Section 5): Re-read this section, paying attention to the summary of findings and the explicit discussion of limitations.

• Key terms/questions to note:

  • What is the difference between incidence and mortality?
  • What are age-standardized rates, and why are they used?
  • What are the primary data sources for GLOBOCAN 2012?
  • What are the main estimation methods used when direct data is unavailable?
  • Which cancer types are globally most common and most lethal for men and women?
  • What are the major geographical disparities in cancer burden?
  • What are the acknowledged limitations of the GLOBOCAN 2012 estimates?

Third pass (1–5 hours)

Using SpatialRead in the Third Pass

• Highlight complex keywords, dense paragraphs, equations, or proofs and ask for a plain-English explanation that preserves notation.
• Use AI to explain the concepts in a way that is easy to understand.
• Ask for alternative phrasings or analogies to confirm understanding without changing technical meaning.
• Connect concepts with each other using AI to build a comprehensive understanding of the paper.
• Download SpatialRead →

The third pass involves a deep, critical reading of the entire paper, scrutinizing the details, and evaluating the validity of its claims.

• Deep reading guidance:

  • Methods (Section 3): Read this section thoroughly. Understand the specific criteria for data quality assessment (3.1). For incidence (3.2) and mortality (3.3) estimation, trace the logic for each estimation method. For example, how are incidence rates estimated from mortality data using mortality-to-incidence ratios (MIRs)? What assumptions underpin these estimations? This is crucial for understanding the robustness and potential biases of the reported figures.
  • Results (Section 4): Read the descriptive text in detail, cross-referencing every claim with the corresponding figures and tables (Figures 1-5, Tables 2-3). Understand the nuances of regional variations and sex-specific patterns. For instance, why are certain cancers more prevalent in specific regions (e.g., liver cancer in East Asia, Figure 4)?
  • Discussion and Limitations (Section 5): Pay critical attention to the limitations. The authors themselves highlight the challenges of data availability and quality, particularly in low-resource settings, and the implications for the accuracy of their estimates. Consider how these limitations might affect your interpretation of the results. What are the implications of using modeled data versus direct registry data?

• Replication pointers if applicable:

  • This paper describes the methodology behind the GLOBOCAN 2012 database rather than a direct experiment to be replicated. However, understanding the "replication" here means comprehending how the estimates were generated.
  • Focus on the detailed descriptions in Section 3 (Methods). If you were tasked with updating or creating a similar global cancer database, this section provides the blueprint: identifying data sources (Table 1), assessing data quality (3.1), and applying specific estimation algorithms for incidence (3.2) and mortality (3.3) based on data availability.
  • While you won't be "running code" from this paper, you can critically assess if, given the described methods and data sources, you would arrive at similar conclusions or if there are alternative approaches you might consider. This deep dive allows you to understand the foundation of the GLOBOCAN data, which is essential for any subsequent analysis or research using these statistics.